Paper I
2019 February (2010 Scheme) · 40 marks · 120 min

Question

Antiplatelet agent

Q170.3 marksShort Answers

Answer

Clopidogrel — irreversibly blocks the P2Y12 ADP receptor on platelets, preventing ADP-mediated platelet activation and aggregation, making it effective for secondary prevention of thrombotic cardiovascular events.

Other Years Asked


Revise MBBS
Preview